FDA Inspection 1225980 — Mayo Clinic Rochester, Division of Transfusion Medicine

Mayo Clinic Rochester, Division of Transfusion Medicine — FEI 2172560

The FDA completed an inspection of Mayo Clinic Rochester, Division of Transfusion Medicine on November 15, 2023 in Rochester, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 15, 2023
Fiscal Year
2024
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Rochester, MN (United States)